|From: singhtelecom (Rep: 971)||Date: 2018-05-11 04:15:24|
|Forum: Spectrum Pharmaceuticals - Thread #674008635||Msg #695 - Part 1/1 (Rec: 0) |
|ROLONTIS® (eflapegrastim) Phase 3 data abstract to be released by American Society of Clinical Oncology (ASCO) followed by an oral presentation at Multinational Association of Supportive Care in Cancer (MASCC) in June 2018.|
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.